These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461 [TBL] [Abstract][Full Text] [Related]
7. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization. Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073 [TBL] [Abstract][Full Text] [Related]
8. Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography. Inoue M; Arakawa A; Yamane S; Kadonosono K Br J Ophthalmol; 2014 Jul; 98(7):956-60. PubMed ID: 24599418 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results. Gharbiya M; Allievi F; Recupero V; Martini D; Mazzeo L; Gabrieli CB Retina; 2009 Jun; 29(6):740-9. PubMed ID: 19516116 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation. Parodi MB; Iacono P; Menchini F; Sheth S; Polini G; Pittino R; Bandello F Acta Ophthalmol; 2013 May; 91(3):267-73. PubMed ID: 21951313 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration. Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization. Yoon JU; Kim YM; Lee SJ; Byun YJ; Koh HJ Retina; 2012 May; 32(5):949-55. PubMed ID: 22534553 [TBL] [Abstract][Full Text] [Related]
13. Two-year course of subfoveal pigment epithelial detachment in eyes with age-related macular degeneration and visual acuity better than 20/40. Baba T; Kitahashi M; Kubota-Taniai M; Oshitari T; Yamamoto S Ophthalmologica; 2012; 228(2):102-9. PubMed ID: 22508168 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration. Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for treatment of subfoveal idiopathic choroidal neovascularization: results of a 1-year prospective trial. Zhang H; Liu ZL; Sun P; Gu F Am J Ophthalmol; 2012 Feb; 153(2):300-306.e1. PubMed ID: 21982109 [TBL] [Abstract][Full Text] [Related]
16. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections. Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476 [TBL] [Abstract][Full Text] [Related]
18. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration]. Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687 [TBL] [Abstract][Full Text] [Related]
19. Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation. Saito M; Shiragami C; Shiraga F; Kano M; Iida T Am J Ophthalmol; 2010 Mar; 149(3):472-81.e1. PubMed ID: 20053392 [TBL] [Abstract][Full Text] [Related]
20. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography. Nagiel A; Sarraf D; Sadda SR; Spaide RF; Jung JJ; Bhavsar KV; Ameri H; Querques G; Freund KB Retina; 2015 Apr; 35(4):638-47. PubMed ID: 25650713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]